KD Logo

Insider Buying: Casdin Partners Master Fund, L, Standard BioTools Inc [LAB] Director invested 100,000 shares

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Standard BioTools Inc shares valued at $260,000 were purchased by Casdin Partners Master Fund, L on May 23 ’24. At $2.60 per share, Casdin Partners Master Fund, L acquired 100,000 shares. The insider’s holdings grew to 46,075,821 shares worth approximately $86.62 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Also, Casdin Partners Master Fund, L purchased 150,000 shares, netting a total of over 387,735 in proceeds. Following the buying of shares at $2.58 each, the insider now holds 45,975,821 shares.

Before that, Casdin Partners Master Fund, L had added 350,000 shares to its account. In a trade valued at $895,930, the Director bought Standard BioTools Inc shares for $2.56 each. Upon closing the transaction, the insider’s holdings increased to 350,000 shares, worth approximately $86.15 million.

As published in their initiating research note from TD Cowen on April 16, 2024, Standard BioTools Inc [LAB] has been a Buy and the price target has been revised to $3.50. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in early April. As of July 12, 2023, KeyBanc Capital Markets has initiated its “an Overweight” rating for LAB.

Analyzing LAB Stock Performance

During the last five days, there has been a surge of approximately 9.30%. Over the course of the year, Standard BioTools Inc shares have dropped approximately -14.93%. Shares of the company reached a 52-week high of $3.0400 on 04/09/24 and a 52-week low of $1.6000 on 06/26/24. A 50-day SMA is recorded $2.3182, while a 200-day SMA reached $2.3456. Nevertheless, trading volume fell to 1.42 million shares from 2.36 million shares the previous day.

Support And Resistance Levels for Standard BioTools Inc (LAB)

According to the 24-hour chart, there is a support level at 1.7767, which, if violated, would cause prices to drop to 1.7133. In the upper region, resistance lies at 1.8967. The next price resistance is at 1.9533. RSI (Relative Strength Index) is 38.22 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1107, which suggests the price will decrease in the coming days. Percent R is at 67.57%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular